Navigation Links
Veran Medical Technologies Welcomes New Member to its Board of Directors
Date:11/18/2013

ST. LOUIS, Nov. 18, 2013 /PRNewswire/ -- Veran Medical Technologies announced today that Curt Hartman, former Chief Financial Officer at Stryker Corporation, was appointed to the company's Board of Directors.

(Photo: http://photos.prnewswire.com/prnh/20131118/PH19057

"Curt has extraordinary medical device leadership experience, as well as a strategic and entrepreneurial mindset that has consistently delivered market leading results. We are delighted that he is joining Veran's Board of Directors," said Jason Pesterfield, Veran's president and chief executive officer. "We are excited to attract the caliber of expertise that Curt Hartman brings to the table and view this as a strong indication of the potential for Veran's success now and in the future."

Mr. Hartman is currently a member of the Board of Directors of Devicor Medical Products, a global medical products company located in Cincinnati, Ohio. Previously, Mr. Hartman held a number of positions of increasing responsibility during a 22-year career with Stryker Corporation. During his tenure he spent four years as the chief financial officer for the $8.7 billion company, preceded by nine years as President of the Stryker Instruments Division. Prior to joining Stryker he served in the United States Army as a helicopter pilot.

"I am excited to join Veran Medical Technologies and work with this exceptional team and board," Mr. Hartman said. "Veran is emerging as the leader in electromagnetic navigation at a time when lung cancer screening is being recommended for early diagnosis. I look forward to sharing my experiences and contributing to the direction and growth of this dynamic organization."

Mr. Hartman received a Bachelor of Science in Aerospace Engineering from the University of Michigan, and completed the Advanced Management Program at Harvard.

In addition to Curt Hartman, Veran's Board of Directors consists of Gregory R. Johnson (chairman), David Adair, M.D., Bob Paulson, Jason Pesterfield and Ajit Shah.

About Veran Medical Technologies. Veran Medical Technologies is a privately held soft tissue navigation company focused on the early diagnosis of cancer.  Multiple specialties use Veran's electromagnetic navigation platform to enhance hospital oncology programs.  The technology is used to assist with lung, kidney and liver procedures endobronchially or percutaneously for biopsies, ablations, drainages and more.   Veran Medical Technologies is headquartered in St. Louis, MO.

Veran Medical Technologies Media Contact
Michelle Berkley, Marketing Manager | 314.659.8500 | www.veranmedical.com

Read more news from Veran Medical Technologies.


'/>"/>
SOURCE Veran Medical Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVBT-Aktionäre stimmen für Veränderungen
2. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
3. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
4. Marken richtet branchenspezifische Diskussionsveranstaltung in Mexiko-Stadt aus
5. Noverant Launches Major Learning Management System Upgrade
6. China Medical Display Industry Report 2013
7. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
8. New Factors Reshaping Medical Education Programs in the Life Sciences Industries
9. Skyline Medical Announces Results for Third Quarter and First Nine Months of 2013
10. Pre-Owned Medical Devices Market is Expected to Reach USD 4.9 Billion Globally in 2019: Transparency Market Research
11. Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec 9, 2016 Research and ... Market 2016-2020" report to their offering. ... The report forecasts the global optical ... period 2016-2020. The report covers the present scenario ... 2016-2020. To calculate the market size, the report considers the revenue ...
(Date:12/9/2016)... 9, 2016 Mitsubishi Tanabe Pharma Corporation (Head ... Director, CEO: Dr. Masayuki Mitsuka ) has presented ... given edaravone intravenously in 10-14 day cycles for 48 ... the ALS Functional Rating Scale-Revised (ALSFRS-R). The data were ... ALS/MND in Dublin, Ireland . ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... 10, 2016 , ... "TransPanel Volume 2 is a package of fading panel ... - CEO of Pixel Film Studios. , TransPanel Volume 2 is a set ... set of versatile transitions features presets with up to 4 panels with complementary line ...
(Date:12/9/2016)... ... 2016 , ... Groth Family Insurance, a Washington-based firm offering ... a charity drive to support the family of Cindy Hendrickson, a local mother ... On October 29th of this year, Cindy Hendrickson swerved to avoid an oncoming ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... its 10th anniversary with the grand opening of the Sober College Robert Pfeifer ... spanned two days, December 2-3, and was attended by an overwhelming amount of ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to ... "I thought that if the nebulizer had a more child-friendly design, then children would ... He developed the patent-pending NEBY to avoid the need to deliver medication via a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
Breaking Medicine News(10 mins):